Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Poveda

Showing results (31-40 of 149) with videos related to

Pageof 15
Sort By:
AIDS Research and Human Retroviruses|October 9, 2007
Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapyEva Poveda, Veronica Briz, Dimitrios Paraskevis, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2010
Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemiaEduardo Seclén, María Del Mar González, Carmen De Mendoza, et al.
Journal of Gastroenterology and Hepatology|November 14, 2013
Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriersÁlvaro Mena, José D Pedreira, Ángeles Castro, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 12, 2011
[Variability in HIV viral tropism determination using different genotypic algorithms in patients infected with B versus non-B HIV-1 subtypes]José Javier Rodríguez, Eduardo Seclén, Eva Poveda, et al.
AIDS Research and Human Retroviruses|February 15, 2011
Short communication: severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regionsEduardo Seclén, Vincent Soriano, María del Mar González, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Viral resistance and genetic barrier of atazanavir]Carmen De Mendoza, Carolina Garrido, Ana Treviño, et al.
AIDS (London, England)|July 19, 2006
Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitorsEva Poveda, Francisco Blanco, Pilar García-Gascó, et al.
Scientific Reports|March 2, 2022
Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort studyAlexandre Pérez-González, Alejandro Araújo-Ameijeiras, Alberto Fernández-Villar, et al.
AIDS Patient Care and Stds|September 4, 2003
Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?Eva Poveda, Carmen de Mendoza, Marta Cuesta, et al.
Journal of Clinical Microbiology|July 8, 2011
High concordance between the position-specific scoring matrix and geno2pheno algorithms for genotypic interpretation of HIV-1 tropism: V3 length as the major cause of disagreementEduardo Seclén, Vicente Soriano, María M González, et al.
Pageof 15

Showing results (31-40 of 149) with videos related to

Sort By:
Pageof 15
AIDS Research and Human Retroviruses|October 9, 2007
Dynamics of drug-resistant HIV-1 in plasma and peripheral blood cells in patients during and after enfuvirtide therapyEva Poveda, Veronica Briz, Dimitrios Paraskevis, et al.
The Journal of Antimicrobial Chemotherapy|May 22, 2010
Dynamics of HIV tropism under suppressive antiretroviral therapy: implications for tropism testing in subjects with undetectable viraemiaEduardo Seclén, María Del Mar González, Carmen De Mendoza, et al.
Journal of Gastroenterology and Hepatology|November 14, 2013
Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriersÁlvaro Mena, José D Pedreira, Ángeles Castro, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 12, 2011
[Variability in HIV viral tropism determination using different genotypic algorithms in patients infected with B versus non-B HIV-1 subtypes]José Javier Rodríguez, Eduardo Seclén, Eva Poveda, et al.
AIDS Research and Human Retroviruses|February 15, 2011
Short communication: severe immune suppression in patients infected with R5-tropic HIV-1 strains is associated with increased gp120 net charge at variable regionsEduardo Seclén, Vincent Soriano, María del Mar González, et al.
Enfermedades Infecciosas Y Microbiologia Clinica|February 2, 2010
[Viral resistance and genetic barrier of atazanavir]Carmen De Mendoza, Carolina Garrido, Ana Treviño, et al.
AIDS (London, England)|July 19, 2006
Successful rescue therapy with darunabir (TMC114) in HIV-infected patients who have failed several ritonavir-boosted protease inhibitorsEva Poveda, Francisco Blanco, Pilar García-Gascó, et al.
Scientific Reports|March 2, 2022
Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort studyAlexandre Pérez-González, Alejandro Araújo-Ameijeiras, Alberto Fernández-Villar, et al.
AIDS Patient Care and Stds|September 4, 2003
Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?Eva Poveda, Carmen de Mendoza, Marta Cuesta, et al.
Journal of Clinical Microbiology|July 8, 2011
High concordance between the position-specific scoring matrix and geno2pheno algorithms for genotypic interpretation of HIV-1 tropism: V3 length as the major cause of disagreementEduardo Seclén, Vicente Soriano, María M González, et al.
Pageof 15